S-P Hojjat1, M Kincal2, R Vitorino2, C G Cantrell3, A Feinstein4, L Zhang2, L Lee5, P O'Connor6, T J Carroll7, R I Aviv8. 1. Medical Imaging (S.-P.H., M.K., R.V., R.I.A., L.Z.), Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Medical Imaging (S.-P.H., R.I.A.), University of Toronto, Toronto, Ontario, Canada Parsa.Hojjat@sunnybrook.ca. 2. Medical Imaging (S.-P.H., M.K., R.V., R.I.A., L.Z.), Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 3. Departments of Biomedical Engineering (C.G.C., T.J.C.). 4. From the Departments of Psychiatry (A.F.) Psychiatry (A.F.). 5. Neurology (L.L.) Departments of Medicine (P.O., L.L.). 6. Departments of Medicine (P.O., L.L.). 7. Departments of Biomedical Engineering (C.G.C., T.J.C.) Radiology (T.J.C.), Northwestern University, Chicago, Illinois. 8. Medical Imaging (S.-P.H., M.K., R.V., R.I.A., L.Z.), Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Medical Imaging (S.-P.H., R.I.A.), University of Toronto, Toronto, Ontario, Canada.
Abstract
BACKGROUND AND PURPOSE: The role of gray matter in multiple sclerosis is increasingly evident; however, conventional images demonstrate limitations in cortical lesion identification. Perfusion imaging appears sensitive to changes in tissue type and disease severity in MS. We sought to use bookend perfusion to quantify parameters in healthy controls and normal-appearing and lesional tissue at different relapsing-remitting MS stages. MATERIALS AND METHODS: Thirty-nine patients with relapsing-remitting MS and 19 age-matched healthy controls were prospectively recruited. The Minimal Assessment of Cognitive Function in MS battery was used to assess cognitive performance. Perfusion parameters, including cerebral blood flow and volume and mean transit time, were compared for healthy controls and normal-appearing and lesional tissue for all study groups. Dispersion of perfusion measures for white matter lesions and cortical lesions was assessed. RESULTS: Twenty of the 39 patients with relapsing-remitting MS were cognitively impaired. Significant differences were displayed between all relapsing-remitting MS subgroups and healthy controls in all comparisons except for normal-appearing gray matter CBV between healthy controls and unimpaired patients with relapsing-remitting MS and for all normal-appearing white matter perfusion parameters between healthy controls and unimpaired patients with relapsing-remitting MS. White matter lesion but not cortical lesion perfusion was significantly reduced in cognitively impaired patients with relapsing-remitting MS versus unimpaired patients with relapsing-remitting MS. Perfusion reduction with disease progression was greater in normal-appearing gray matter and normal-appearing white matter compared with cortical lesions and white matter lesions. Smaller dispersion was observed for cortical lesions compared with white matter lesions for each perfusion parameter. CONCLUSIONS: Quantitative GM and WM analysis demonstrated significant but disproportionate white matter lesion, cortical lesion, normal-appearing white matter, and normal-appearing gray matter changes present between healthy controls and patients with relapsing-remitting MS with and without cognitive impairment, necessitating absolute rather than relative lesion perfusion measurement.
BACKGROUND AND PURPOSE: The role of gray matter in multiple sclerosis is increasingly evident; however, conventional images demonstrate limitations in cortical lesion identification. Perfusion imaging appears sensitive to changes in tissue type and disease severity in MS. We sought to use bookend perfusion to quantify parameters in healthy controls and normal-appearing and lesional tissue at different relapsing-remitting MS stages. MATERIALS AND METHODS: Thirty-nine patients with relapsing-remitting MS and 19 age-matched healthy controls were prospectively recruited. The Minimal Assessment of Cognitive Function in MS battery was used to assess cognitive performance. Perfusion parameters, including cerebral blood flow and volume and mean transit time, were compared for healthy controls and normal-appearing and lesional tissue for all study groups. Dispersion of perfusion measures for white matter lesions and cortical lesions was assessed. RESULTS: Twenty of the 39 patients with relapsing-remitting MS were cognitively impaired. Significant differences were displayed between all relapsing-remitting MS subgroups and healthy controls in all comparisons except for normal-appearing gray matter CBV between healthy controls and unimpaired patients with relapsing-remitting MS and for all normal-appearing white matter perfusion parameters between healthy controls and unimpaired patients with relapsing-remitting MS. White matter lesion but not cortical lesion perfusion was significantly reduced in cognitively impairedpatients with relapsing-remitting MS versus unimpaired patients with relapsing-remitting MS. Perfusion reduction with disease progression was greater in normal-appearing gray matter and normal-appearing white matter compared with cortical lesions and white matter lesions. Smaller dispersion was observed for cortical lesions compared with white matter lesions for each perfusion parameter. CONCLUSIONS: Quantitative GM and WM analysis demonstrated significant but disproportionate white matter lesion, cortical lesion, normal-appearing white matter, and normal-appearing gray matter changes present between healthy controls and patients with relapsing-remitting MS with and without cognitive impairment, necessitating absolute rather than relative lesion perfusion measurement.
Authors: Ken E Sakaie; Wanyong Shin; Kenneth R Curtin; Richard M McCarthy; Ty A Cashen; Timothy J Carroll Journal: J Magn Reson Imaging Date: 2005-05 Impact factor: 4.813
Authors: Laëtitia Debernard; Tracy R Melzer; Saskia Van Stockum; Charlotte Graham; Claudia Am Wheeler-Kingshott; John C Dalrymple-Alford; David H Miller; Deborah F Mason Journal: J Neurol Neurosurg Psychiatry Date: 2013-09-13 Impact factor: 10.154
Authors: Seyed-Parsa Hojjat; Charles Grady Cantrell; Timothy J Carroll; Rita Vitorino; Anthony Feinstein; Lying Zhang; Sean P Symons; Sarah A Morrow; Liesly Lee; Paul O'Connor; Richard I Aviv Journal: Mult Scler Date: 2016-02-04 Impact factor: 6.312
Authors: Meng Law; Amit M Saindane; Yulin Ge; James S Babb; Glyn Johnson; Lois J Mannon; Joseph Herbert; Robert I Grossman Journal: Radiology Date: 2004-06 Impact factor: 11.105
Authors: R M D'Ortenzio; S P Hojjat; R Vitorino; C G Cantrell; L Lee; A Feinstein; P O'Connor; T J Carroll; R I Aviv Journal: AJNR Am J Neuroradiol Date: 2016-09-29 Impact factor: 3.825
Authors: Melanie D Sweeney; Kassandra Kisler; Axel Montagne; Arthur W Toga; Berislav V Zlokovic Journal: Nat Neurosci Date: 2018-09-24 Impact factor: 24.884
Authors: Cristina Granziera; Jens Wuerfel; Frederik Barkhof; Massimiliano Calabrese; Nicola De Stefano; Christian Enzinger; Nikos Evangelou; Massimo Filippi; Jeroen J G Geurts; Daniel S Reich; Maria A Rocca; Stefan Ropele; Àlex Rovira; Pascal Sati; Ahmed T Toosy; Hugo Vrenken; Claudia A M Gandini Wheeler-Kingshott; Ludwig Kappos Journal: Brain Date: 2021-06-22 Impact factor: 13.501
Authors: Zafer Keser; Khader M Hasan; Benson Mwangi; Kyan Younes; Mahsa Khayat-Khoei; Arash Kamali; John A Lincoln; Flavia M Nelson Journal: Front Neurol Date: 2018-03-12 Impact factor: 4.003
Authors: Mar Jiménez de la Peña; Ignacio Casanova Peña; Pablo García-Polo García; Miguel López Gavilán; Norberto Malpica; Margarita Rubio; Rafael Arroyo González; Vicente Martínez de Vega Journal: Acta Radiol Open Date: 2019-12-30
Authors: Richard J Dury; Yasser Falah; Penny A Gowland; Nikos Evangelou; Molly G Bright; Susan T Francis Journal: Eur Radiol Date: 2018-10-02 Impact factor: 5.315